IVD Firms Need To Plan Ahead For EU IVD Directive, Consultant Advises
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers should begin preparations for the April 2000 implementation of the European Union In Vitro Diagnostics Directive, Maurizio Suppo, principal consultant for Belgium-based MTC advised at an Oct. 28 Regulatory Affairs Professional Society meeting in Washington, D.C.
You may also be interested in...
Underwriters Laboratory Joins Growing List of Notified Bodies For IVDD
Underwriters Laboratory (UL) plans to expand its notified body (NB) certification status to include the full scope of in vitro diagnostic products by early 2001.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.